Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by diyodton Mar 19, 2012 5:36pm
370 Views
Post# 19691817

Financing at 45% ?

Financing at 45% ?

This loan better be prepayable or we just gave away potentially a huge wad of cash. Here's my numbers. we can assume no significant MCC sales except for canine.

I am assuming that the 15% interest rate is annualized, rather than over the 5yr term.

Loan interest:          =  15% x 5 yrs =       3.0m x 5 = 15mil 

plus

Annual revenue x 2% over 5 yrs =     (30m x .02 x 5) = 3.0 m

plus lets assume that GM is actually thruthful and we start decreasing the burn rate of 1 m / month. That must include a big  increase in revenue. Lets say they manage it by 75% revenue increase and 25% cut in expenses(lol)

that would make the revenue increase for say the last 40 months from late 2013 equal (40 x .75m) x.02 for royalty = another 0.6 mill

That equals an interest total of 18.6 m (almost the whole loan)

But what if Econiche sales arise as expected (say 75%) production from 2013 or 30 million doses with a revenue of $8 per dose = 240m x 2% x 5 yrs =  24 mil

So we could potentially be paying out around 40-45 mill or 40-45% annualized.

I hope SEDAR or someone else here proves me wrong, or this deal stinks.

 

 

 

Bullboard Posts